These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33895991)

  • 1. Should we be routinely co-prescribing naloxone for patients on long term opioids?
    Prathivadi P; Nielsen S
    Med J Aust; 2021 May; 214(9):403-404.e1. PubMed ID: 33895991
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability of Naloxone Co-Prescription Among Primary Care Providers Treating Patients on Long-Term Opioid Therapy for Pain.
    Behar E; Rowe C; Santos GM; Coffa D; Turner C; Santos NC; Coffin PO
    J Gen Intern Med; 2017 Mar; 32(3):291-295. PubMed ID: 27815762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing Naloxone Access and Prescribing for Patients on High-Dose Opioids From a Managed Care Pharmacy Health Plan Perspective.
    Hansgen JP; Robertson ML; Verzino EM; Manning LM
    J Pharm Pract; 2024 Dec; 37(6):1291-1296. PubMed ID: 38685768
    [No Abstract]   [Full Text] [Related]  

  • 5. Naloxone prescribing to older adults in primary care.
    Luther CD; Hughes TD; Ferreri SP
    J Am Geriatr Soc; 2021 Dec; 69(12):3681-3683. PubMed ID: 34383967
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of fatal opioid overdose.
    Beletsky L; Rich JD; Walley AY
    JAMA; 2012 Nov; 308(18):1863-4. PubMed ID: 23150005
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescription Opioid Misuse and Overuse in the U.S.
    Fleming DA
    Mo Med; 2018; 115(3):189-190. PubMed ID: 30228715
    [No Abstract]   [Full Text] [Related]  

  • 8. Racial inequities in U.S. naloxone prescriptions.
    Madden EF; Qeadan F
    Subst Abus; 2020; 41(2):232-244. PubMed ID: 31718487
    [No Abstract]   [Full Text] [Related]  

  • 9. Naloxone-Prescribing Practices: A Missed Opportunity.
    Stone S; Barnes E; McLouth CJ; McNeil CJ
    N C Med J; 2018; 79(5):343-344. PubMed ID: 30228147
    [No Abstract]   [Full Text] [Related]  

  • 10. [Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth].
    Noufi P; Khoury E; Ayoub E; Naccache N; Richa S
    Encephale; 2016 Dec; 42(6):511-516. PubMed ID: 27776797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergency department naloxone distribution: a Rhode Island department of health, recovery community, and emergency department partnership to reduce opioid overdose deaths.
    Samuels E
    R I Med J (2013); 2014 Oct; 97(10):38-9. PubMed ID: 25271659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States.
    Sohn M; Talbert JC; Huang Z; Lofwall MR; Freeman PR
    JAMA Netw Open; 2019 Jun; 2(6):e196215. PubMed ID: 31225895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National opioid prescription patterns and patient usage after routine vasectomy.
    Asanad K; Nusbaum DJ; Samplaski MK
    Andrologia; 2020 Jun; 52(5):e13563. PubMed ID: 32196718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Rhode Island community responds to opioid overdose deaths.
    Bowman S; Engelman A; Koziol J; Mahoney L; Maxwell C; McKenzie M
    R I Med J (2013); 2014 Oct; 97(10):34-7. PubMed ID: 25271658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between a State Law Allowing Pharmacists to Dispense Naloxone Without a Prescription and Naloxone Dispensing Rates.
    Gangal NS; Hincapie AL; Jandarov R; Frede SM; Boone JM; MacKinnon NJ; Koechlin K; DeFiore-Hyrmer J; Holthusen A; Heaton PC
    JAMA Netw Open; 2020 Jan; 3(1):e1920310. PubMed ID: 32003819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Provider Prescription Drug Monitoring Program Utilization and Self-Auditing-A Pilot Study.
    Brown WC; Whitted K
    J Dr Nurs Pract; 2020 Jul; 13(2):142-147. PubMed ID: 32817503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery.
    Bachyrycz A; Shrestha S; Bleske BE; Tinker D; Bakhireva LN
    Subst Abus; 2017; 38(1):55-60. PubMed ID: 27164192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient, family members and community pharmacists' views of a proposed overdose prevention intervention delivered in community pharmacies for patients prescribed high-strength opioids for chronic non-cancer pain: An explorative intervention development study.
    Mercer F; Parkes T; Foster R; Steven D; McAuley A; Baldacchino A; Steele W; Schofield J; Matheson C
    Drug Alcohol Rev; 2023 Mar; 42(3):517-526. PubMed ID: 36165733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone Co-prescribing to Patients Receiving Prescription Opioids in the Medicare Part D Program, United States, 2016-2017.
    Jones CM; Compton W; Vythilingam M; Giroir B
    JAMA; 2019 Aug; 322(5):462-464. PubMed ID: 31386124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Datapoints: regional variation in benzodiazepine prescribing for patients on opioid agonist therapy.
    Park TW; Bohnert AS; Austin KL; Saitz R; Pizer SD
    Psychiatr Serv; 2014 Jan; 65(1):4. PubMed ID: 24382761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.